{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:03:34Z","timestamp":1790089414759,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05925-2","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:52:34Z","timestamp":1790041954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Physiologically based pharmacokinetic modeling of diazepam: quantitative assessment of hepatic impairment and model-informed dose optimization in patients with liver cirrhosis"],"prefix":"10.1007","author":[{"given":"Yu-Jin","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7515-0631","authenticated-orcid":false,"given":"Seung-Hyun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"issue":"2","key":"5925_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2125.1994.tb04336.x","volume":"38","author":"T Andersson","year":"1994","unstructured":"Andersson T, Miners JO, Veronese ME, Birkett DJ (1994) Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms. Br J Clin Pharmacol 38(2):131\u2013137","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"5925_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1021\/cn5000056","volume":"5","author":"NE Calcaterra","year":"2014","unstructured":"Calcaterra NE, Barrow JC (2014) Classics in chemical neuroscience: diazepam (valium). ACS Chem Neurosci 5(4):253\u2013260","journal-title":"ACS Chem Neurosci"},{"issue":"8","key":"5925_CR3","first-page":"903","volume":"25","author":"DJ Carlile","year":"1997","unstructured":"Carlile DJ, Zomorodi K, Houston JB (1997) Scaling factors to relate drug metabolic clearance in hepatic microsomes, isolated hepatocytes, and the intact liver: studies with induced livers involving diazepam. Drug Metab Dispos 25(8):903\u2013911","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"5925_CR4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2165\/00002018-200528060-00005","volume":"28","author":"F Delc\u00f2","year":"2005","unstructured":"Delc\u00f2 F, Tchambaz L, Schlienger R, Drewe J, Kr\u00e4henb\u00fchl S (2005) Dose Adjustment in Patients with Liver Disease. Drug Saf 28(6):529\u2013545","journal-title":"Drug Saf"},{"issue":"4","key":"5925_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/03602532.2017.1377223","volume":"49","author":"RJ Dinis-Oliveira","year":"2017","unstructured":"Dinis-Oliveira RJ (2017) Metabolic profile of oxazepam and related benzodiazepines: clinical and forensic aspects. Drug Metab Rev 49(4):451\u2013463","journal-title":"Drug Metab Rev"},{"issue":"3","key":"5925_CR6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s11224-022-02029-4","volume":"34","author":"R Djebaili","year":"2023","unstructured":"Djebaili R, Kenouche S, Daoud I, Melkemi N, Belkadi A, Mesli F (2023) Investigation of [3H]diazepam derivatives as allosteric modulators of GABAA receptor \u03b11\u03b22\u03b32 subtypes: combination of molecular docking\/dynamic simulations, pharmacokinetics\/drug-likeness prediction, and QSAR analysis. Struct Chem 34(3):791\u2013823","journal-title":"Struct Chem"},{"issue":"5","key":"5925_CR7","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.3390\/ijms24054543","volume":"24","author":"M Drozdzik","year":"2023","unstructured":"Drozdzik M, Lapczuk-Romanska J, Wenzel C et al (2023) Protein abundance of drug metabolizing enzymes in human hepatitis C livers. Int J Mol Sci 24(5):4543","journal-title":"Int J Mol Sci"},{"issue":"11","key":"5925_CR8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.2165\/00003088-200847110-00005","volume":"47","author":"AN Edginton","year":"2008","unstructured":"Edginton AN, Willmann S (2008) Physiology-based simulations of a pathological condition. Clin Pharmacokinet 47(11):743\u2013752","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"5925_CR9","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/neurolint13040059","volume":"13","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN, Nix CA, Hollier J et al (2021) Benzodiazepines: uses, dangers, and clinical considerations. Neurol Int 13(4):594\u2013607","journal-title":"Neurol Int"},{"issue":"6","key":"5925_CR10","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/00007691-198911000-00007","volume":"11","author":"DJ Greenblatt","year":"1989","unstructured":"Greenblatt DJ, Harmatz JS, Friedman H, Locniskar A, Shader RI (1989) A large-sample study of diazepam pharmacokinetics. Ther Drug Monit 11(6):652\u2013657","journal-title":"Ther Drug Monit"},{"issue":"3","key":"5925_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/cpt1974163part1485","volume":"16","author":"L Hillestad","year":"1974","unstructured":"Hillestad L, Hansen T, Melsom H (1974) Diazepam metabolism in normal man. II. Serum concentration and clinical effect after oral administration and cumulation. Clin Pharmacol Ther 16(3):485\u2013489","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"5925_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.eplepsyres.2009.01.001","volume":"84","author":"VD Ivaturi","year":"2009","unstructured":"Ivaturi VD, Riss JR, Kriel RL, Siegel RA, Cloyd JC (2009) Bioavailability and tolerability of intranasal diazepam in healthy adult volunteers. Epilepsy Res 84(2):120\u2013126","journal-title":"Epilepsy Res"},{"key":"5925_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-3-030-73503-6_15","volume-title":"Drug-induced Neurological Disorders","author":"KK Jain","year":"2021","unstructured":"Jain KK (2021) Drug-Induced Disturbances of Consciousness. In: Jain KK (ed) Drug-induced Neurological Disorders. Springer International Publishing, Cham, pp 233\u2013264"},{"issue":"11","key":"5925_CR14","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1016\/j.xphs.2022.08.035","volume":"111","author":"S-H Jeong","year":"2022","unstructured":"Jeong S-H, Jang J-H, Lee Y-B (2022) Physiologically based pharmacokinetic (PBPK) modeling of lornoxicam: exploration of doses for CYP2C9 genotypes and patients with cirrhosis. J Pharm Sci 111(11):3174\u20133184","journal-title":"J Pharm Sci"},{"key":"5925_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-026-05191-2","author":"S-H Jeong","year":"2026","unstructured":"Jeong S-H, Jang J-H, Kang H-S (2026) Physiologically based pharmacokinetic modeling of immediate-release and extended-release formulations of doxazosin, an alpha-1 adrenergic receptor antagonist, with model simulations for patients with liver disease. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-026-05191-2","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"5925_CR16","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/med.70026","volume":"46","author":"H Jiang","year":"2026","unstructured":"Jiang H, Hu Z, Yang L et al (2026) The evolution of benzodiazepine allosteric modulators: structural insights from historical milestones to emerging innovations in drug discovery and development. Med Res Rev 46(3):561\u2013584","journal-title":"Med Res Rev"},{"issue":"3","key":"5925_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2165\/11318160-000000000-00000","volume":"49","author":"TN Johnson","year":"2010","unstructured":"Johnson TN, Boussery K, Rowland-Yeo K, Tucker GT, Rostami-Hodjegan A (2010) A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance. Clin Pharmacokinet 49(3):189\u2013206","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"5925_CR18","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/jps.2600621111","volume":"62","author":"SA Kaplan","year":"1973","unstructured":"Kaplan SA, Jack ML, Alexander K, Weinfeld RE (1973) Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations. J Pharm Sci 62(11):1789\u20131796","journal-title":"J Pharm Sci"},{"issue":"18","key":"5925_CR19","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/BF01489215","volume":"56","author":"U Klotz","year":"1978","unstructured":"Klotz U (1978) Clinical pharmacokinetics of diazepam and its biologically active metabolites. Klin Wochenschr 56(18):895\u2013904","journal-title":"Klin Wochenschr"},{"issue":"2","key":"5925_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1172\/JCI107938","volume":"55","author":"U Klotz","year":"1975","unstructured":"Klotz U, Avant G, Hoyumpa A, Schenker S, Wilkinson G (1975) The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest 55(2):347\u2013359","journal-title":"J Clin Invest"},{"issue":"4","key":"5925_CR21","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/cpt1977214430","volume":"21","author":"U Klotz","year":"1977","unstructured":"Klotz U, Antonin KH, Br\u00fcgel H, Bieck PR (1977) Disposition of diazepam and its major metabolite desmethyldiazepam in patients with liver disease. Clin Pharmacol Ther 21(4):430\u2013436","journal-title":"Clin Pharmacol Ther"},{"key":"5925_CR22","first-page":"1","volume-title":"NeuroPsychopharmacotherapy","author":"Y Knyahnytska","year":"2020","unstructured":"Knyahnytska Y, Abbaspour Z, Kendzerska T (2020) Tranquilizer\/Anxiolytics: Benzodiazepines (Long-Acting) \u2013 Chlordiazepoxide, Clorazepate, Diazepam, Ethyl Loflazepate, Flutoprazepam, Medazepam, Mexazolam, Nitrazepam, Oxazolam. In: Riederer P, Laux G, Nagatsu T, Le W, Riederer C (eds) NeuroPsychopharmacotherapy. Springer International Publishing, Cham, pp 1\u201319"},{"key":"5925_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-3-032-15772-0_13","volume-title":"Clinical Psychopharmacology for Neurologists: A Practical Guide","author":"V Kumar","year":"2026","unstructured":"Kumar V, Kinsella LJ (2026) Psychiatric Adverse Effects of Nonpsychiatric Medications. In: Grossberg GT, Kinsella LJ (eds) Clinical Psychopharmacology for Neurologists: A Practical Guide. Springer Nature Switzerland, Cham, pp 233\u2013249"},{"issue":"12","key":"5925_CR24","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/jcph.70079","volume":"65","author":"S-M Lee","year":"2025","unstructured":"Lee S-M, Jang J-H, Jeong S-H (2025) Precision pharmacokinetics of quetiapine: a physiologically based model incorporating liver cirrhosis and CYP3A4 polymorphisms. J Clin Pharmacol 65(12):1719\u20131731","journal-title":"J Clin Pharmacol"},{"issue":"8","key":"5925_CR25","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s11095-022-03274-2","volume":"39","author":"W Lin","year":"2022","unstructured":"Lin W, Chen Y, Unadkat JD, Zhang X, Wu D, Heimbach T (2022) Applications, challenges, and outlook for PBPK modeling and simulation: a regulatory, industrial and academic perspective. Pharm Res 39(8):1701\u20131731","journal-title":"Pharm Res"},{"issue":"2","key":"5925_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/00004714-198304000-00006","volume":"3","author":"M Linnoila","year":"1983","unstructured":"Linnoila M, Erwin CW, Brendle A, Simpson D (1983) Psychomotor Effects of Diazepam in Anxious Patients and Healthy Volunteers. J Clin Psychopharmacol 3(2):88\u201396","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"5925_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2165\/00003088-197803010-00005","volume":"3","author":"M Mandelli","year":"1978","unstructured":"Mandelli M, Tognoni G, Garattini S (1978) Clinical pharmacokinetics of diazepam. Clin Pharmacokinet 3(1):72\u201391","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"5925_CR28","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1248\/bpb.28.1711","volume":"28","author":"T Niwa","year":"2005","unstructured":"Niwa T, Shiraga T, Ishii I, Kagayama A, Takagi A (2005) Contribution of human hepatic cytochrome p450 isoforms to the metabolism of psychotropic drugs. Biol Pharm Bull 28(9):1711\u20131716","journal-title":"Biol Pharm Bull"},{"issue":"6","key":"5925_CR29","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1365-2125.1979.tb01044.x","volume":"8","author":"EE Ohnhaus","year":"1979","unstructured":"Ohnhaus EE, Park BK, Colombo JP, Heizmann P (1979) The effect of enzyme induction on diazepam metabolism in man. Br J Clin Pharmacol 8(6):557\u2013563","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"5925_CR30","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.3109\/00498259609050260","volume":"26","author":"S Onof","year":"1996","unstructured":"Onof S, Hatanaka T, Miyazawa S et al (1996) Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily. Xenobiotica 26(11):1155\u20131166","journal-title":"Xenobiotica"},{"key":"5925_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-981-97-4283-7_5","volume-title":"A Short Guide to Clinical Pharmacokinetics","author":"R Peeriga","year":"2024","unstructured":"Peeriga R, Manubolu K (2024) Effect of Renal and Hepatic Diseases on Pharmacokinetics. In: Manubolu K, Peeriga R, Chandrasekhar KB (eds) A Short Guide to Clinical Pharmacokinetics. Springer Nature Singapore, Singapore, pp 67\u201395"},{"key":"5925_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-981-19-6045-1_4","volume-title":"Peri-operative Anesthetic Management in Liver Transplantation","author":"A Trikha","year":"2023","unstructured":"Trikha A, Ray BR (2023) Pathophysiology of Chronic Liver Disease. In: Vohra V, Gupta N, Jolly AS, Bhalotra S (eds) Peri-operative Anesthetic Management in Liver Transplantation. Springer Nature Singapore, Singapore, pp 51\u201362"},{"issue":"12","key":"5925_CR33","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","volume":"64","author":"RK Verbeeck","year":"2008","unstructured":"Verbeeck RK (2008) Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol 64(12):1147\u20131161","journal-title":"Eur J Clin Pharmacol"},{"issue":"S274","key":"5925_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1600-0447.1978.tb02388.x","volume":"58","author":"GR Wilkinson","year":"1978","unstructured":"Wilkinson GR (1978) The effects of liver disease and aging on the disposition of diazepam, chlordiazepoxide, oxazepam and lorazepam in man. Acta Psychiatr Scand 58(S274):56\u201374","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"5925_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2710.2007.00795.x","volume":"32","author":"A Yamazaki","year":"2007","unstructured":"Yamazaki A, Kumagai Y, Fujita T et al (2007) Different effects of light food on pharmacokinetics and pharmacodynamics of three benzodiazepines, quazepam, nitrazepam and diazepam. J Clin Pharm Ther 32(1):31\u201339","journal-title":"J Clin Pharm Ther"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05925-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05925-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05925-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:24:47Z","timestamp":1790087087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05925-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":35,"alternative-id":["5925"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05925-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"12 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}